TCTR20180610001
Completed
未知
Comparison of topical recombinant human epidermal growth factor versus aloe vera gel in combination with ablative 10,600-nm carbon dioxide fractional laser for the treatment of striae alba: A randomized, double-blind trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Striae alba
- Sponsor
- Thammasat University
- Enrollment
- 24
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •subjects aged 20\-60, in good health, with striae alba on both sides of abdomen, thigh or buttock, able to remain 5kg of their starting weight during the study and avoid any non\-study treatment of striae during the whole study period
Exclusion Criteria
- •history of keloids or hypertrophic scar, skin infection or other active skin disease on the study areas, use of immunosuppressive drug or systemic retinoid within past 2 months, any treatment including laser for striae within 1 year prior to study initiation, allergy to local anesthesia (e.g. lidocaine or prilocaine).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The clinical benefit of topical moisturizers in xerosis patientDiseases of the skin and subcutaneous tissueKCT0001508Samsung Medical Center80
Not yet recruiting
Phase 4
Assesing the comparative ability of Human epidermal growth factor and the Insulin-like growth factor-1 coated membranes in the treatment of receeding gums.CTRI/2024/04/066294Sibar Institute of Dental Sciences
Not yet recruiting
Phase 4
To compare the clinical outcome of topical recombinant human epidermal growth factor and conventional saline dressing in management of diabetic foot ulcers - a randomised controlled trialCTRI/2024/06/068922Aarupadai veedu medical College and hospital
Not yet recruiting
Phase 3
Effect of topical recombinant human epidermal growth factor on chronic diabetic ulcer compared with conventional saline dressingCTRI/2024/05/067239Dr A Sneha Daffodil
Recruiting
Phase 3
The efficacy of topical recombinant human epidermal growth factor gel in combination with fractional radiofrequency microneedle in the treatment of mild to moderate atrophic acne scarmild to moderate rolling and shallow boxcar acne scarsTCTR20201201003none20